[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100605250":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":18,"centralContacts":18,"locations":25,"responsibleParty":115,"collaborators":119,"id":123,"slug":124,"hasResults":125,"nctId":126,"briefTitle":127,"officialTitle":128,"acronym":129,"eligibilityCriteria":130,"healthyVolunteers":131,"sex":132,"minAge":133,"maxAge":18,"enrollmentInfo":134,"targetDuration":18,"studyType":137,"phases":138,"briefSummary":140,"conditions":141,"keywords":143,"overallStatus":67,"whyStopped":18,"lastUpdateSubmitDate":148,"lastUpdatePostDateStruct":149,"startDateStruct":152,"completionDateStruct":154,"leadSponsor":156,"locationsCount":157},{"fullName":5,"class":6},"University of Saskatchewan","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"PrEP Group","EXPERIMENTAL","Participants who have agreed to be on PrEP",[13],"Behavioral: Simultaneous administration of OAT and oral PrEP at existing pharmacy-based programs",{"label":15,"type":16,"description":17,"interventionNames":18},"Non-PrEP Group","NO_INTERVENTION","Participants who have declined PrEP",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":18},"BEHAVIORAL","Simultaneous administration of OAT and oral PrEP at existing pharmacy-based programs","Simultaneous administration of OAT and oral PrEP (direct observed therapy or home supply) at existing pharmacy-based programs",[9],[26,48,65,84,95,105],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Sheldon M Chumir Health Centre","NOT_YET_RECRUITING","Calgary","Alberta","T2R 0X7","Canada","CA",{"type":35,"coordinates":36},"Point",[37,38],-114.08529,51.05011,{"lat":38,"lon":37},[41,46],{"name":42,"role":43,"phone":44,"phoneExt":18,"email":45},"Caley Shukalek, MD, MPH","CONTACT","403-210-6093","cbshukal@ucalgary.ca",{"name":42,"role":47,"phone":18,"phoneExt":18,"email":18},"PRINCIPAL_INVESTIGATOR",{"facility":49,"status":28,"city":50,"state":51,"zip":52,"country":32,"countryCode":33,"cosmosGeoPoint":53,"geoPoint":57,"contacts":58},"Queen City Wellness Pharmacy","Regina","Saskatchewan","S4P 0H7",{"type":35,"coordinates":54},[55,56],-104.6178,50.45008,{"lat":56,"lon":55},[59,63],{"name":60,"role":43,"phone":61,"phoneExt":18,"email":62},"Sarah Kozusko, BScPharm","306-522-2266","skozusko@rubiconpharmacies.com",{"name":64,"role":47,"phone":18,"phoneExt":18,"email":18},"Cara Spence, PhD",{"facility":66,"status":67,"city":68,"state":51,"zip":69,"country":32,"countryCode":33,"cosmosGeoPoint":70,"geoPoint":74,"contacts":75},"Mayfair Drugs Pharmacy","RECRUITING","Saskatoon","S7L 0V8",{"type":35,"coordinates":71},[72,73],-106.66892,52.13238,{"lat":73,"lon":72},[76,80,83],{"name":77,"role":43,"phone":78,"phoneExt":18,"email":79},"Christine McDougall, RN","306-370-2320","mcdougall.christine@gmail.com",{"name":81,"role":43,"phone":18,"phoneExt":18,"email":82},"Chantelle Wong, BSc.","chw454@usask.ca",{"name":64,"role":47,"phone":18,"phoneExt":18,"email":18},{"facility":85,"status":67,"city":68,"state":51,"zip":86,"country":32,"countryCode":33,"cosmosGeoPoint":87,"geoPoint":89,"contacts":90},"Pharmasave Riversdale Pharmacy","S7M 0Y2",{"type":35,"coordinates":88},[72,73],{"lat":73,"lon":72},[91,93,94],{"name":77,"role":43,"phone":92,"phoneExt":18,"email":79},"1-306-370-2320",{"name":81,"role":43,"phone":18,"phoneExt":18,"email":82},{"name":64,"role":47,"phone":18,"phoneExt":18,"email":18},{"facility":96,"status":67,"city":68,"state":51,"zip":97,"country":32,"countryCode":33,"cosmosGeoPoint":98,"geoPoint":100,"contacts":101},"The Medicine Shoppe Pharmacy","S7M 0Z7",{"type":35,"coordinates":99},[72,73],{"lat":73,"lon":72},[102,103,104],{"name":77,"role":43,"phone":78,"phoneExt":18,"email":79},{"name":81,"role":43,"phone":18,"phoneExt":18,"email":82},{"name":64,"role":47,"phone":18,"phoneExt":18,"email":18},{"facility":106,"status":67,"city":68,"state":51,"zip":107,"country":32,"countryCode":33,"cosmosGeoPoint":108,"geoPoint":110,"contacts":111},"Meadowgreen Pharmacy","S7M 4R5",{"type":35,"coordinates":109},[72,73],{"lat":73,"lon":72},[112,113,114],{"name":77,"role":43,"phone":78,"phoneExt":18,"email":79},{"name":81,"role":43,"phone":18,"phoneExt":18,"email":82},{"name":64,"role":47,"phone":18,"phoneExt":18,"email":18},{"type":116,"investigatorFullName":117,"investigatorTitle":118,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"SPONSOR_INVESTIGATOR","Cara Spence","Lead Principal Investigator in Saskatchewan, Canada",[120],{"name":121,"class":122},"Gilead Sciences","INDUSTRY","100605250","phase-4-hiv-prevention-with-prep-among-people-on-opioid-replacement-therapy-100605250",false,"NCT07160075","HIV Prevention With PrEP Among People on Opioid Replacement Therapy","Improving Access to HIV Pre-exposure Prophylaxis: Implementation and Evaluation of Innovative HIV Prevention Services Among Persons on Opioid Replacement Therapy in Western Canada: Prospective, Implementation Study","OAT-PrEP","Inclusion Criteria:\n\n* HIV negative\n* Ongoing behaviors with potential HIV exposure as assessed by a clinician\n* Regularly engaged with their respective OAT program at least 3 days a week for the past 2 weeks\n* Report willingness to return for follow-up visits\n\nExclusion Criteria:\n\n* Creatine clearance \\\u003C30 mL\u002Fmin or any medical condition or medication known to be contraindicated with the use of Emtricitabine\u002FTenofovir Alafenamide (F\u002FTAF) or Emtricitabine\u002FTenofovir Disoproxil Fumarate (F\u002FTDF)\n* Taken PrEP within the last 24 hours at the time of screening or enrollment\n* Deemed appropriate by a clinician for HIV Post-Exposure Prophylaxis at the time of screening or enrollment",true,"ALL","16 Years",{"count":135,"type":136},350,"ESTIMATED","INTERVENTIONAL",[139],"PHASE4","The purpose of this study is to assess the feasibility and acceptability of providing oral pre-exposure prophylaxis (PrEP) and opioid agonist therapy (OAT) simultaneously in existing pharmacy-based programs operating in Alberta and Saskatchewan, to collect preference, adherence, and persistence data on oral PrEP, and to assess interest \u002F acceptability of long-lasting injectable options for human immunodeficiency virus (HIV) prevention.",[142],"HIV - Human Immunodeficiency Virus",[144,145,146,147],"PrEP","OAT","Opioid Agonist Therapy","HIV","2025-10-01",{"date":150,"type":151},"2025-10-07","ACTUAL",{"date":153,"type":151},"2025-08-28",{"date":155,"type":136},"2027-09-01",{"name":117,"class":6},6]